Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Feigin

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of Huntington'S Disease|May 3, 2024
What Huntington's Disease Patients Say About Their Illness: An Online Direct-to-Participant Pilot StudyKaren E Anderson, Lakshmi Arbatti, Abhishek Hosamath, et al.
Parkinsonism & Related Disorders|February 2, 2021
Art therapy for Parkinson's diseaseAlberto Cucca, Alessandro Di Rocco, Ikuko Acosta, et al.
Nature Medicine|September 5, 2025
Pridopidine in early-stage manifest Huntington's disease: a phase 3 trialRalf Reilmann, Andrew Feigin, Anne E Rosser, et al.
JCI Insight|April 14, 2017
Long-term follow-up of a randomized AAV2-<i>GAD</i> gene therapy trial for Parkinson's diseaseMartin Niethammer, Chris C Tang, Peter A LeWitt, et al.
The Lancet. Neurology|March 23, 2011
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trialPeter A LeWitt, Ali R Rezai, Maureen A Leehey, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2016
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced DyskinesiaClaudia Trenkwalder, Daniela Berg, Olivier Rascol, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|February 18, 2016
National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and BarriersE Ray Dorsey, Meredith A Achey, Christopher A Beck, et al.
Neurology|August 18, 2017
National randomized controlled trial of virtual house calls for Parkinson diseaseChristopher A Beck, Denise B Beran, Kevin M Biglan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2004
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onsetNancy S Wexler, Judith Lorimer, Julie Porter, et al.
Neurology|December 4, 2016
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael McDermott, Karl Kieburtz, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of Huntington'S Disease|May 3, 2024
What Huntington's Disease Patients Say About Their Illness: An Online Direct-to-Participant Pilot StudyKaren E Anderson, Lakshmi Arbatti, Abhishek Hosamath, et al.
Parkinsonism & Related Disorders|February 2, 2021
Art therapy for Parkinson's diseaseAlberto Cucca, Alessandro Di Rocco, Ikuko Acosta, et al.
Nature Medicine|September 5, 2025
Pridopidine in early-stage manifest Huntington's disease: a phase 3 trialRalf Reilmann, Andrew Feigin, Anne E Rosser, et al.
JCI Insight|April 14, 2017
Long-term follow-up of a randomized AAV2-<i>GAD</i> gene therapy trial for Parkinson's diseaseMartin Niethammer, Chris C Tang, Peter A LeWitt, et al.
The Lancet. Neurology|March 23, 2011
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trialPeter A LeWitt, Ali R Rezai, Maureen A Leehey, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2016
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced DyskinesiaClaudia Trenkwalder, Daniela Berg, Olivier Rascol, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|February 18, 2016
National Randomized Controlled Trial of Virtual House Calls for People with Parkinson's Disease: Interest and BarriersE Ray Dorsey, Meredith A Achey, Christopher A Beck, et al.
Neurology|August 18, 2017
National randomized controlled trial of virtual house calls for Parkinson diseaseChristopher A Beck, Denise B Beran, Kevin M Biglan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2004
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onsetNancy S Wexler, Judith Lorimer, Julie Porter, et al.
Neurology|December 4, 2016
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Michael McDermott, Karl Kieburtz, et al.
Pageof 7